Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer
-
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
-
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
-
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
-
Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting
-
THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality
-
BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program
-
Roofing Expert Keith Miller Clarifies Why Flashing Is the Source of Many Roof Leaks in HelloNation
-
RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative
-
Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
-
Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days
-
Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs
-
Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting
-
JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
-
JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025
-
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at
-
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematolog
-
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
-
Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
-
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist
-
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meet
-
Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compo
-
Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
-
Canada’s Tenth Costco Business Centre is now open in East Gwillimbury
-
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
-
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
-
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Societ
-
BI DeFi Launches New Daily Yield Plan as Demand for Accessible Crypto Income Solutions Grows
-
DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion
-
New Crypto Coin Mutuum Finance Nears 100% of Phase 6 Allocation as Price Shift Approaches
-
Scatec starts commercial operation at Grootfontein solar power plant in South Africa
-
Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families
-
Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients
-
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
-
ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress
-
Copper Quest Closes $1,927,000 Private Placement
-
AB Value Partners, L.P. Announces Proposed Settlement of Stockholder Class Action on Behalf of Former Holders of Orbit/FR, Inc. Common Stock - ORFR
-
HNI Corporation Announces Expiration and Final Results of Exchange Offer
-
Guardian Capital Announces Estimated 2025 Annual Non-Cash Distributions for Guardian Capital ETFs
-
Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group
-
LocationSync Releases New Consumer Insights Highlighting Nationwide Shift Toward Comfort-Driven Home Upgrades
-
Colabor Group Announces Resignation of Director
-
Sable Announces Adoption of New Equity Incentive Plan
-
Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
-
Connell Consulting Business Agency, LLC makes lobbying debut addressing Personal Injury Protection (PIP) loophole
-
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
-
Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q
-
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
-
CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th
-
Children’s National Hospital welcomes First Lady Melania Trump for holiday visit
